🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Quadriceps Tendon vs Peroneus Longus Tendon in ACL Reconstruction

RecruitingNAAges 18 Years - 50 YearsAllAcibadem University
NCT07671729 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective randomized clinical trial aims to compare quadriceps tendon and peroneus longus tendon autografts in anterior cruciate ligament reconstruction. Patients with anterior cruciate ligament injury undergoing primary reconstruction surgery will be randomly assigned to one of the two graft groups. Clinical examination findings, return-to-sport outcomes, ankle muscle strength, ankle-related functional scores, and gait analysis parameters will be evaluated at 6 months and 12 months postoperatively. The study aims to investigate both knee-related functional outcomes and donor site morbidity associated with graft harvesting techniques.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with anterior cruciate ligament rupture * Patients scheduled for primary anterior cruciate ligament reconstruction * Age between 18 and 50 years * Ability to provide informed consent * Willingness to comply with postoperative rehabilitation and follow-up evaluations Exclusion Criteria: * Previous ligament reconstruction surgery on the affected knee * Multi-ligament knee injuries requiring additional ligament reconstruction * Severe osteoarthritis of the knee * Revision anterior cruciate ligament reconstruction * Neuromuscular disorders affecting lower extremity function * Active infection * Inability to comply with follow-up protocol
💊

What it tests

  • Anterior Cruciate Ligament Reconstruction Using Quadriceps Tendon Autograft
  • Anterior Cruciate Ligament Reconstruction Using Peroneus Longus Tendon Autograft
📍

Where

1 site
Acibadem Fulya Hospital, Sport Medicine Center
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy